Sumeet Singh-Tan
Howard I. Sherman
Colon cancer screening<quillbot-extension-portal></quillbot-extension-portal>
Colon cancer screening<quillbot-extension-portal></quillbot-extension-portal>
<p>Howard I. Sherman, MD, is an attending physician and Adjunct Associate Clinical Professor, Gastroenterology at Montefiore Einstein. His clinical focus centers on colon cancer screening.</p><p>After earning his Doctor of Medicine at Einstein in 1973, Dr. Sherman began his postdoctoral training at Emory University. There, he completed his medical internship in 1974, his internal medicine residency in 1976 and a digestive diseases fellowship in 1978.</p><p>Building on his clinical focus, Dr. Sherman’s research is focused on colon cancer screening.</p><p>Dr. Sherman is board certified in Gastroenterology and is a Diplomat of the National Board of Medical Examiners and the American Board of Internal Medicine. He is a member of several professional organizations, including the American Gastroenterology Association, the American College of Gastroenterology, the American Society for Gastrointestinal Endoscopy and the American Association for the Study of Liver Disease.</p>
Jonathan M. Schwartz
<p>Jonathan M. Schwartz is a board Certified Transplant Hepatologist. He is a graduate of Tel Aviv University, Sackler School of Medicine. He was an Internal Medicine Resident at Albert Einstein College of Medicine and a Fellow in Gastroenterology/Transplant Hepatology at the University of Washington in Seattle. He returned to New York in 2011 from Portland, Oregon where he served as an Associate Professor of Medicine at Oregon Health and Sciences University.</p>
<p>Dr. Schwartz has an interest in treating patients with acute and chronic liver diseases including those patients with advanced liver diseases who require liver transplantation.</p>
<p>He has a special interest in the multidisciplinary care of patients with liver tumors.</p>
<p><strong><br /></strong></p>
<ul>
<li>Estes JD, Stolpman D, Olyaei A, Ham JM, <strong>Schwartz JM</strong>, Orloff SL. High Prevalence of Potentially Hepatotoxic Herbal Supplement Use in Fulminant Hepatic Failure Patients. Arch Surg. 2003;138(8):852-8.</li>
<li><strong>Schwartz JM</strong>, Beymer C, Althaus SJ, Larson AM, Zaman A, Glickerman D, Kowdley KV. Cardiopulmonary Consequences of Transjugular Intrahepatic Portosystemic Shunts: Role of Increased Pulmonary Artery Pressure. J Clin Gastroenterol 2004;38(7):590-594.</li>
<li>Lim LL, Scarborough J, Thorne J, Graham E, Kempen J, Mackensen F, Nguyen Q D, Prabriputaloong T, Read R, Suhler EB, <strong>Schwartz JM</strong>, Smith JR. Uveitis in Patients with Autoimmune Hepatitis. Am J Ophthalmol. 2009;147(2):332-338.</li>
<li>O’Glasser AY, Scott DA, Corless CL, Zaman A, Sasaki A, Gopal DV, Rayhill SC, Orloff SL, Ham JM, Rabkin JM, Flora K, Davies CH, Broberg CS, and <strong>Schwartz JM.</strong>Hepatic and Cardiac Iron Overload Among Patients with End-Stage Liver Disease Referred for Liver Transplantation. Clinical Transplantation. Clin Transplant. 2010 Sep-Oct;24(5):643-51.</li>
<li>Kanwal F, Befeler A, Chari R, Marrero J, Kahn J, Afdhal N, Morgan T, Roberts L, Mohanty SR, <strong>Schwartz J</strong>, Van Thiel D, Hassanein TI, Li J, Zeringue A, DiBisceglie A. Rate of Potentially Curative Treatment in Patients with Hepatocellular Carcinoma. Aliment Pharmacol Ther. 2012 Aug;36(3):257-65.</li>
<li>Bichoupan K1, <strong>Schwartz JM,</strong> Martel-Laferriere V, Giannattasio ER, Marfo K, Odin JA, Liu LU, Schiano TD, Perumalswami P, Bansal M, Gaglio PJ, Kalia H,Dieterich DT, Branch AD, Reinus JF. Effect of Fibrosis on Adverse Events in Patients with Hepatitis C Treated with Telaprevir. Aliment Pharmacol Ther. 2014;39(2):209-16.</li>
<li><strong>Schwartz J</strong> and Carithers RL. Epidemiology and Etiologic Associations of Primary Hepatocellular Carcinoma. In Rose BD, editor. Up to date in Gastroenterology and Hepatology. Up to date, Inc. Wellesley, MA, Updated 2014.</li>
<li><strong>Schwartz JM </strong>and Carithers RL, Jr. Clinical features, diagnosis, and screening for primary hepatocellular carcinoma. Up to date in Gastroenterology and Hepatology. Up to date, Inc. Wellesley, MA, Updated 2014.</li>
<li>Curley SA, Stewart KE, <strong>Schwartz JM</strong>, Carthers RL, Jr. Nonsurgical therapies for localized hepatocellular carcinoma. Up to date, Inc. Wellesley, MA, Updated 2014.<strong> </strong></li>
<li><strong>Schwartz JM</strong>. Approach to the patient with a focal liver lesion. Up to date Inc Gastroenterology and Hepatology. Up to date, Inc. Wellesley, MA, Updated 2014.</li>
<li>Hartwell L and <strong>Schwartz JM. </strong>AsymptomaticLiver Chemistry Abnormalities. Journal of Clinical Outcomes Management. 2009; 16 (11): 525-34.</li>
<li>Urquhart J<strong>, Schwartz, JM.</strong> Hepatocellular Carcinoma Surveillance in a Western Population with Hepatitis B. Current Hepatitis Reports, 2011.</li>
<li><strong>Schwartz, JM </strong>and Reinus JF. Prevalence and Natural History of Alcoholic Liver Disease. Clinics in Liver Disease. 2012; 16 (4): 659-66.</li>
</ul>
<p> </p>
Evelyn M. Rondinel
Amira M. Mohamed
Amira Mohamed completed her medical school education in Khartoum, Sudan before moving to the United States. She completed an internal medicine residency and sub-specialized in Critical Care Medicine after which she joined Montefiore Medical Center in 2019.<br />Dr. Mohamed became involved in the medical education of both internal medicine residents and critical care medicine fellows soon after joining Montefiore and was appointed the Associate Program Director of the Critical Care Medicine Fellowship Program in early 2021. She rebuilt the fellow curriculum and strengthened their involvement in non-clinical duties such as research and quality improvement. She became the Program Director in 2022.<br />Outside of medical education, Dr. Mohamed is the Associate Director of the Medical Intensive Care Unit at the Moses campus and her research interests include vaccine effectiveness and healthcare disparities.
Amira Mohamed is an intensivist with a specific interest in Acute Respiratory Distress Syndrome (ARDS) and respiratory failure. As the Associate Director of the Medical Intensive Care Unit at the Moses campus, she is involved in multiple quality improvement projects such as ventilator liberation with spontaneous awakening and breathing trials and measures to decrease Central Line Associated Blood Stream Infections.<br />As an intensivist and a clinical educator, Dr. Mohamed's focus has been on resident and fellow education. She has contributed to the recent changes in the Critical Care Curriculum with a renewed focus on research and quality improvement. During the COVID-19 pandemic, Dr. Mohamed joined the ICY network in a CDC-funded study of vaccine effectiveness and has published multiple studies on this topic.
<p>Amira Mohamed, MD, is Director, Critical Care Fellowship Program, Associate Director, Medical Intensive Care Unit, Moses Campus and Assistant Professor, Medicine at Montefiore Einstein. Dr. Mohamed is an intensivist with a specific interest in Acute Respiratory Distress Syndrome (ARDS) and respiratory failure.</p><p>After completing her medical school education in Khartoum, Sudan in 2012, Dr Mohamed later moved to the United States. She completed her internal medicine residency at Mount Sinai Medical Center in 2017, followed by a critical care medicine fellowship at Mount Sinai Hospital, Icahn School of Medicine in 2019, acting as Chief Fellow in her final year.</p><p>Dr. Mohamed’s research interests include vaccine effectiveness and health care disparities. As an intensivist and a clinical educator, Dr Mohamed's focus has been on resident and fellow education. She has contributed to recent changes of the critical care curriculum at Montefiore Einstein, with a renewed focus on research and quality improvement. She has shared her research through peer-reviewed journals, book chapters and abstracts.</p><p>Dr. Mohamed is board certified in Internal Medicine and Critical Care Medicine. She is a member of the American Thoracic Society, the Society of Critical Care Medicine and the Association of Pulmonary and Critical Care Medicine Program Directors.</p>
Haleh Moazen
Rishabh Mishra
Maria Y. Mazing
<p>My research interest is in internal medicine/hospital medicine.</p>